• Company
    • About STADA
    • Management
    • Our corporate culture
    • STADA worldwide
    • Company history
    • Compliance
  • Products
    • Consumer Healthcare products
    • Specialty Pharmaceuticals
    • Generics
    • Partnerships
    • Quality at STADA
    • Adverse drug reaction report
  • Stories
  • Sustainability
    • Sustainability Report
    • Supply Chain Act
  • Investors
    • At a Glance
    • Corporate Governance
    • IR Contact
  • Media
    • Newsroom
    • Press Releases
    • Media assets
    • STADA Health Report
    • Media Contact
  • Career
en-GB
Chevron Down IconChevron Down Icon
  • DeutschDeutsch (DE-DE)
  • Company
    • About STADA
    • Management
    • Our corporate culture
    • STADA worldwide
    • Company history
    • Compliance
  • Products
    • Consumer Healthcare products
    • Specialty Pharmaceuticals
    • Generics
    • Partnerships
    • Quality at STADA
    • Adverse drug reaction report
  • Stories
  • Sustainability
    • Sustainability Report
    • Supply Chain Act
  • Investors
    • At a Glance
    • Corporate Governance
    • IR Contact
  • Media
    • Newsroom
    • Press Releases
    • Media assets
    • STADA Health Report
    • Media Contact
  • Career
  1. Home IconHome Icon
  2. Media
  3. Health Reports
  4. STADA Health Report 2023
DownloadArrow Right IconArrow Right Icon
Prevention
Mental Health
War and Crisis
Cough and Cold
Pain Management
Chronic Diseases
Methodology

Prevention - STADA Health Report 2023

How important is health prevention for Europeans
How important is health prevention for Europeans
Almost 9 in 10 Europeans do not receive adequate preventive healthcare
Almost 9 in 10 Europeans do not receive adequate preventive healthcare
Only 1 in 2 women get regular checks for breast cancer
Only 1 in 2 women get regular checks for breast cancer
Mens health checks even less frequented than womens
Mens health checks even less frequented than womens
Lack of education and cost main barriers for preventive health screenings
Lack of education and cost main barriers for preventive health screenings

 

 

 

Nizoral® Grippostad® Lunestil® Immunology Nephrology Neurology
About us Products Investors Media Career STADA worldwide
Contact [email protected] +49 6101 603-0 Compliance Reporting Portal ⧉
FOLLOW US
LinkedIn IconLinkedIn IconInstagram IconInstagram IconFacebook IconFacebook IconTwitter IconTwitter IconYouTube IconYouTube Icon
  • Conditions of Use
  • Privacy Policy
  • Imprint
  • Cookie Settings
Progenerika | © Copyright STADA Arzneimittel AG 2025